Drug Research
INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact
INOVIO, a biotechnology company focused on precisely designed DNA medicines to treat and prevent infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou, an emerging biotech company with next-gen technology in vaccines, have entered into a collaboration and license agreement...
Drug Research
Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804
Incyte and Cellenkos, Inc., a privately held, clinical stage biotech company, announced a development collaboration to investigate the combination of ruxolitinib (Jakafi®) and CK0804, Cellenkos’ cryopreserved CXCR4 enriched, allogeneic, umbilical cord blood-derived T-regulatory cells, in patients with myelofibrosis (MF)....
Drug Research
Moderna Provides COVID-19 Vaccine Supply Update
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, provided a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global production estimate from 500 to 600 million doses for 2021. Moderna said it is...
Drug Research
Treating brain disorders with new nanoparticle drug delivery system
A new nanoparticle drug-delivery system could help scientists overcome the long-standing problem of delivering therapeutics across the blood-brain barrier and into the brain.
Progress has been made over the past few decades in identifying biological pathways that lead to neurodegenerative...
Drug Research
Pfizer, OPKO One Step Closer to Approval of Pediatric Growth Hormone Deficiency Drug
Pfizer and OPKO Health are one step closer to receiving approval for their jointly developed pediatric growth hormone deficiency (GHD) drug, somatrogon, after the U.S. FDA recently accepted the companies’ regulatory submission for the therapy.
The FDA accepted for filing...
Drug Research
Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that Israel’s Ministry of Health (MOH) has given authorization to import the COVID-19 Vaccine Moderna in Israel.
“Today’s authorization is a landmark moment in our company’s history...
Drug Research
Recipharm and Moderna finalize agreement for aseptic drug product manufacturing and fill-finish for supply to countries outside the U.S.
Moderna, Inc., biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Recipharm, a leading contract development and manufacturing organization (CDMO), announced that they have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read